Akari Therapeutics Plc (AKTX)

7.47 -0.38 (-4.84%) USD  |  NASDAQ  |  Aug 24, 16:00
7.52 +0.05 (+0.67%) After-Hours: 20:00
More

Akari Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2025. Start Trial.
Date Value
August 17, 2026 --
July 20, 2026 --
June 30, 2026 --
April 22, 2026 --
April 08, 2026 --
April 01, 2026 --
March 31, 2026 --
March 11, 2026 --
Date Value
March 05, 2026 --
January 05, 2026 --
December 31, 2025 --
December 22, 2025 --
September 09, 2025 --
August 14, 2025 --
July 18, 2025 --
June 30, 2025 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
DBV Technologies SA Upgrade
Cellectis SA Upgrade
argenx SE Upgrade
Autolus Therapeutics Plc Upgrade
Evaxion AS Upgrade

Revenue Estimates for Current Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade